From: Transtheoretical model-based mobile health application for PCOS
Measured parameter | Baseline | 6-month | 12-month | F(time*group) | P value |
---|---|---|---|---|---|
BMI | 12.8 | 0.00** | |||
 Intervention group | 25.99 ± 3.87 | 23.40 ± 1.69 | 22.63 ± 1.97 |  |  |
 Control group | 25.25 ± 3.95 | 25.36 ± 3.06 | 24.86 ± 2.65 |  |  |
 t-value | 0.89 | − 3.7 | 6.55 |  |  |
 P-value | 0.38 | 0.00** | 0.00** |  |  |
WC | 2.44 | 0.04* | |||
 Intervention group | 86.22 ± 9.91 | 81.54 ± 8.54 | 80.50 ± 6.94 |  |  |
 Control group | 87.64 ± 6.59 | 86.75 ± 5.52 | 85.44 ± 7.95 |  |  |
 t-value | − 0.79 | − 3.44 | − 3.14 |  |  |
 P-value | 0.43 | 0.00** | 0.00** |  |  |
SAS | 0.91 | 0.016* | |||
 Intervention group | 46.97 ± 6.53 | 42.91 ± 6.65 | 42.12 ± 9.69 |  |  |
 Control group | 49.02 ± 7.05 | 47.83 ± 6.27 | 46.46 ± 8.91 |  |  |
 t-value | − 1.23 | − 3.49 | − 2.14 |  |  |
 P-value | 0.223 | 0.001** | 0.035* |  |  |
SDS | 8.41 | 0.000*** | |||
 Intervention group | 51.55 ± 6.78 | 46.83 ± 5.36 | 40.57 ± 5.41 |  |  |
 Control group | 52.29 ± 6.86 | 50.57 ± 5.42 | 49.24 ± 7.14 |  |  |
 t-value | 0.5 | − 2.72 | − 6.24 |  |  |
 P-value | 0.621 | 0.008** | 0.000*** |  |  |